Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Medpace Holdings is a global clinical contract research organization (CRO) providing outsourced drug development services. Medpace provides a...
— Vulcan Value Partners LLC
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Medpace Holdings, Inc.
Medpace is a global clinical contract research organization featuring a robust balance sheet and strong cash generation. While near-term growth...
Our investments in drug development companies like Charles River Labs (CRL) and Medpace Holdings (MEDP) pulled back, driven by AI disruption fears.
Medpace posted strong Q2 results that beat expectations on both top and bottom lines, leading to a full-year guidance upgrade. Furthermore, massive share...
More institutional theses from Vulcan Value Partners - Focus Plus
Forterra is one of the top UK brick manufacturers supported by long-term structural demand and pricing leverage. Although higher interest...
Carlyle Group possesses stable long-term capital across private equity, credit, and solutions. Expected interest rate...
Virtus reported solid cash flow conversion and stable net fee rates alongside modest AUM growth. The company's distribution...